Calluna Pharma

Calluna Pharma is a clinical-stage biotechnology company focused on developing novel therapies for inflammatory and fibrotic diseases. Their approach targets upstream innate immune amplifiers, aiming to disrupt the root causes of these conditions and offer a potential solution for a wide range of medical conditions. Calluna Pharma's pipeline includes several first-in-class therapeutic antibodies, with their lead candidate, CAL101, targeting S100A4 to address diseases like idiopathic pulmonary fibrosis, chronic kidney disease, and rheumatoid arthritis.

Calluna Pharma's commitment to scientific excellence and clinical development is reflected in their team, comprised of experienced professionals from academic institutions and large pharmaceutical companies. They are also backed by notable industry investors, including Forbion, highlighting the company's potential and commercial promise. With a mission to revolutionize the treatment landscape for inflammatory and fibrotic diseases, Calluna Pharma seeks to improve patient outcomes and deliver life-changing therapies.

Calluna Pharma is a clinical-stage biopharmaceutical company dedicated to developing novel therapies that target the root causes of chronic inflammation and fibrosis. By leveraging over 30 years of scientific research, they have unlocked a groundbreaking therapeutic concept that aims to disrupt disease progression and restore tissue homeostasis. They believe that by targeting upstream innate immune amplifiers, they can create a more effective and safer treatment approach for a wide range of inflammatory and fibrotic diseases, ultimately improving patient outcomes.

Calluna Pharma promotes a culture of scientific excellence and innovation, fostering a collaborative environment where diverse backgrounds and expertise are valued. The company encourages a commitment to improving patient outcomes and developing therapies that address unmet medical needs, reflecting a passion for making a real difference in the lives of those living with serious diseases.

Calluna Pharma values diversity and inclusion. The company website highlights its team's blend of skills and backgrounds, drawing from academic institutions and both biotech and large pharma companies. This diverse expertise fosters a collaborative environment that prioritizes the development of innovative therapies.